Morphine Sulfate
Class:
Opiod analgesic (Schedule II drug).
Opiod analgesic (Schedule II drug).
Mechanism of Action:
- Alleviates pain through CNS actions.
- Suppresses fear and anxiety centers in brain.
- Depresses brain stem respiratory centers.
- Decreases preload and afterload, decreasing myocardial oxygen demand.
Indications:
- Analgesia for moderate to severe acute and chronic pain (use with caution).
- Severe CHF, pulmonary edema.
- Chest pain associated with acute MI.
Contraindications:
- Head injury
- Exacerbated COPD.
- Depressed respiratory drive.
- Hypotension undiagnosed abdominal pain.
- Decreased level of conciousness.
- Suspected hypovolemia.
Adverse reactions:
Respiratory depression, hypotension, decreased level of consciousness, nausea, vomiting, bradycardia, tachycardia, syncope, facial flushing, euphoria, bronchospasm, dry mouth.
Respiratory depression, hypotension, decreased level of consciousness, nausea, vomiting, bradycardia, tachycardia, syncope, facial flushing, euphoria, bronchospasm, dry mouth.
Adult Dosage and Administration
0.1 mg/kg to a maximum of 10 mg IV/IM/SC.
0.1 mg/kg to a maximum of 10 mg IV/IM/SC.
🧸
Pediatric Dosage and Administration0.1 - 0.2 mg/kg / dose IV, IO, IM, SC every 5 minutes titrated to max. of 5 mg.
Duration of Action
- Onset: Immediate.
- Peak effect: 20 minutes.
- Duration: 2 - 7 hours.
Special Considerations:
- Pregnancy safety: Category C.
- Morphine rapidly crosses the placenta.
- Safety in neonate not established.
- Use with caution in geriatric population and those with COPD, asthma.
- Naloxone should be readily available as antidote.